Wilbanks Smith & Thomas Asset Management LLC Fennec Pharmaceuticals Inc. Call Options Transaction History
Wilbanks Smith & Thomas Asset Management LLC
- $3.54 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FENC
# of Institutions
82Shares Held
14MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$33.5 Million0.98% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$19.8 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.23MShares$18.4 Million12.03% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$9.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA967KShares$7.95 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $214M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...